Biotech

Latest News

[ October 22, 2024 ] Sequoia Capital and the evolution of the VC industry | FT Film Consumer
[ October 19, 2024 ] Apollo CEO Marc Rowan on Private Markets, US Election, Fed Interest Rates Consumer
[ October 18, 2024 ] Stan Druckenmiller on Fed Policy, Election, Bonds, Nvidia Market News
[ September 19, 2024 ] Midnight Sun Announces Start of Kazhiba Exploration Program News Feed
[ September 5, 2024 ] Pro-Dex, Inc. Announces Fiscal 2024 Fourth Quarter and Full-Year Results Market News
[ August 20, 2024 ] FingerMotion’s Advanced Command and Communication (C2) Platform Awarded National Certification from China’s Ministry of Industry and Information Technology News Feed
[ July 24, 2024 ] Peer To Peer Network (PTOP) Announces Strategic Partnership With Beantown Advertising For Digital Advertising Campaign News Feed

Citius Provides Update on Its CITI Platforms and Gives Investors Further Insight on their Licensing Agreement with MD Anderson Cancer Center

January 17, 2019 The Wall Street Analyzer Comments Off

Citius Pharmaceuticals (NASDAQ: CTXR) CEO: Myron Holubiak About: Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets. Citius products offer new and […]

Valeritas Announces that V-Go® Insulin Delivery is Now Available in New Zealand

August 1, 2018 The Wall Street Analyzer Comments Off

“We are delighted to announce patients with type 2 diabetes in New Zealand now have access to V-Go® Wearable Insulin Delivery device,” said Valeritas CEO, John Timberlake. […]

VBI Vaccines (NASDAQ: VBIV) CEO Interview Update

April 26, 2018 The Wall Street Analyzer Comments Off

Interview with Jeff Baxter, CEO […]

TapImmune Announces Publication of Clinical Trial Results for the TPIV200 Cancer Vaccine in Clinical Cancer Research

March 15, 2018 The Wall Street Analyzer Comments Off

Phase 1 Demonstration of Safety and Long-Lasting Immune Responses in Ovarian and Breast Cancer […]

Avenue Therapeutics, Inc. (NASDAQ:ATXI) CEO Interview

March 13, 2018 The Wall Street Analyzer Comments Off

Interview with Dr. Lucy Lu, CEO and President […]

Biocept Reports Third Quarter 2017 Financial Results

November 14, 2017 The Wall Street Analyzer Comments Off

(NASDAQ: BIOC) […]

InMed Pharmaceuticals Inc. (CSE: IN) (OTCQB: IMLFF) CEO Interview

October 13, 2017 The Wall Street Analyzer Comments Off

Interview with CEO Eric Adams […]

NuLife Sciences (OTCQB: NULF) CEO Interview

October 6, 2017 The Wall Street Analyzer Comments Off

Interview with CEO John Hollister […]

SQI Diagnostics (TSXV:SQD)(OTCQX:SQIDF) CEO: Andrew Morris

April 11, 2017 The Wall Street Analyzer Comments Off

Interview with CEO Andrew Morris […]

Diversicare Healthcare Services (NASDAQ:DVCR) Management Interview

October 4, 2016 The Wall Street Analyzer Comments Off

Management Interview […]

Featured Interviews

FingerMotion, Inc (NASDAQ: FNGR)

July 18, 2024 0

ABOUT: FingerMotion is an evolving technology company with a core competency in mobile payment and recharge platform solutions in China.As the user base of its primary business continues to grow, the Company is developing additional value-added technologies to market to its users. The vision of the Company is to rapidly grow the user base through organic means and have this growth develop into an ecosystem of users with high engagement rates utilizing its innovative applications. Developing a highly engaged ecosystem of users would strategically position the Company to onboard larger customer bases. FingerMotion eventually hopes to serve over 1 billion users in the China market and eventually expand the model to other regional markets. For more information on FingerMotion, visit: https://fingermotion.com/ […]